Klingenstein Fields & Co Portfolio holdings
Klingenstein Fields & Co., which does business as Klingenstein Fields Advisors, is an independently owned wealth manager for high net worth individuals, families, foundations and nonprofits. Its roots lie in Wertheim & Company, a merchant bank started by Joseph Klingenstein and Maurice Wertheim, which later joined with Schroder as Wertheim Schroder. Frederick Klingenstein, who had led Wertheim's expansion into investment banking and investment management, left Wertheim Schroder with John Klingenstein and Ken Fields to form Klingenstein Fields. It provides wealth planning and investment management built around each client's goals.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookfield
BN
|
+$12.1M |
| 2 |
Johnson & Johnson
JNJ
|
+$10.3M |
| 3 |
Starbucks
SBUX
|
+$2.32M |
| 4 |
Schwab International Equity ETF
SCHF
|
+$823K |
| 5 |
Schwab U.S Small- Cap ETF
SCHA
|
+$777K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Paramount Global Class B
PARA
|
+$14.9M |
| 2 |
SLB Ltd
SLB
|
+$9.4M |
| 3 |
DuPont de Nemours
DD
|
+$2.62M |
| 4 |
PayPal
PYPL
|
+$1.78M |
| 5 |
PepsiCo
PEP
|
+$1.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.92% |
| 2 | Industrials | 15.32% |
| 3 | Communication Services | 14.26% |
| 4 | Financials | 13.81% |
| 5 | Technology | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Walt Disney
DIS
$205B
| $115M | 5.79% |
796,090
-11,664
| -1% | -$1.63M |
2013 Q2
26 quarters
|
|
|
2
Johnson & Johnson
JNJ
$688B
| $89.5M | 4.5% |
613,762
+75,668
| +14% | +$10.3M |
2013 Q2
26 quarters
|
|
|
3
PepsiCo
PEP
$198B
| $77.7M | 3.91% |
568,308
-12,530
| -2% | -$1.71M |
2013 Q2
26 quarters
|
|
4
Union Pacific
UNP
$180B
| $66.8M | 3.36% |
369,274
-4,685
| -1% | -$802K |
2013 Q2
26 quarters
|
|
5
Berkshire Hathaway Class B
BRK.B
$1.26T
| $64.8M | 3.26% |
286,083
-4,182
| -1% | -$908K |
2013 Q2
26 quarters
|
|
6
Comcast
CMCSA
$89.3B
| $51.8M | 2.61% |
1,152,682
+14,786
| +1% | +$658K |
2013 Q2
26 quarters
|
|
|
7
Schwab International Equity ETF
SCHF
$67.5B
| $45.1M | 2.27% |
2,684,360
+50,026
| +2% | +$823K |
2016 Q1
15 quarters
|
|
|
8
PayPal
PYPL
$49.2B
| $42.7M | 2.15% |
394,893
-17,090
| -4% | -$1.78M |
2015 Q3
17 quarters
|
|
9
Honeywell
HON
$70.6B
| $38.4M | 1.93% |
230,064
-7,550
| -3% | -$1.23M |
2013 Q2
26 quarters
|
|
10
Amazon
AMZN
$2.88T
| $37.2M | 1.87% |
403,000
+900
| +0.2% | +$79.7K |
2013 Q2
26 quarters
|
|
11
RTX Corp
RTX
$268B
| $34.9M | 1.75% |
370,062
-12,531
| -3% | -$1.14M |
2013 Q2
26 quarters
|
|
12
Microsoft
MSFT
$3.89T
| $34.5M | 1.74% |
219,066
-3,535
| -2% | -$519K |
2013 Q2
26 quarters
|
|
|
RTN
13
DELISTED
Raytheon Company
RTN
| $33.1M | 1.66% |
150,507
-5,797
| -4% | -$1.23M |
2013 Q2
26 quarters
|
|
|
14
Schwab U.S Small- Cap ETF
SCHA
$22B
| $32.4M | 1.63% |
1,712,660
+42,952
| +3% | +$777K |
2016 Q2
14 quarters
|
|
15
Colgate-Palmolive
CL
$79.2B
| $31.7M | 1.59% |
460,298
-7,501
| -2% | -$511K |
2013 Q2
26 quarters
|
|
16
JPMorgan Chase
JPM
$919B
| $31.2M | 1.57% |
224,107
-3,612
| -2% | -$463K |
2013 Q2
26 quarters
|
|
17
Thermo Fisher Scientific
TMO
$259B
| $31.2M | 1.57% |
96,143
-2,673
| -3% | -$811K |
2015 Q2
18 quarters
|
|
18
Alphabet (Google) Class A
GOOGL
$3.64T
| $31.2M | 1.57% |
465,920
-12,080
| -3% | -$779K |
2015 Q4
16 quarters
|
|
19
Broadcom
AVGO
$1.66T
| $31M | 1.56% |
980,750
-23,460
| -2% | -$712K |
2016 Q2
14 quarters
|
|
20
Merck
MRK
$364B
| $30.1M | 1.52% |
347,223
-7,615
| -2% | -$625K |
2013 Q2
26 quarters
|
|
|
RDS.A
21
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $29.9M | 1.51% |
507,051
-7,156
| -1% | -$418K |
2013 Q2
26 quarters
|
|
22
Meta Platforms (Facebook)
META
$1.64T
| $29.4M | 1.48% |
143,326
-1,516
| -1% | -$294K |
2013 Q2
26 quarters
|
|
23
Crown Castle
CCI
$38.6B
| $29.1M | 1.46% |
204,698
-5,618
| -3% | -$766K |
2015 Q3
17 quarters
|
|
24
American Tower
AMT
$88.9B
| $28.8M | 1.45% |
125,403
-3,581
| -3% | -$780K |
2013 Q2
26 quarters
|
|
25
Labcorp
LH
$30.1B
| $28.5M | 1.44% |
196,349
-2,820
| -1% | -$407K |
2013 Q2
26 quarters
|
|
Similar funds
Klingenstein Fields & Co's Q4 2019 Portfolio in Review
As of Q4 2019, Klingenstein Fields & Co held 194 positions worth $1.99B, up 4.9% from $1.89B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Klingenstein Fields & Co's Q4 2019 filing shows 3 new, 32 increased, 103 reduced and 7 closed positions. Its largest new stake was iShares Russell 2000 ETF: 1,812 shares worth $300K. The largest sale was Paramount Global Class B, an estimated $14.9M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Industrials and Communication Services.
- Klingenstein Fields & Co's largest Q4 2019 buy was iShares Russell 2000 ETF: 1,812 shares worth $300K.
- Klingenstein Fields & Co added most to Brookfield in Q4 2019, an estimated $12.1M increase.
- Klingenstein Fields & Co's biggest Q4 2019 reduction was SLB Ltd, cutting an estimated $9.4M.
- Klingenstein Fields & Co fully exited Paramount Global Class B in Q4 2019, selling an estimated $14.9M.
- Klingenstein Fields & Co's ten largest holdings make up 32% of its $1.99B portfolio in Q4 2019.
- Klingenstein Fields & Co opened 3 new positions and closed 7 in Q4 2019.
- Klingenstein Fields & Co's portfolio value rose 4.9% quarter-over-quarter to $1.99B.
Based on Klingenstein Fields & Co's 13F filing for Q4 2019, filed 4 Feb 2020.